Back to search results

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Israel
RecruitingPHASE1

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Conditions

Advanced Solid Tumor Cancer

Locations
  • University of Arizona Cancer Center - Tucson /ID# 262698, Tucson, Arizona, United States
  • Yale University School of Medicine /ID# 225707, New Haven, Connecticut, United States
  • Johns Hopkins Hospital /ID# 254056, Baltimore, Maryland, United States
  • Beth Israel Deaconess Medical Center /ID# 252009, Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute /ID# 249642, Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 252010, Ann Arbor, Michigan, United States
  • NYU Laura and Isaac Perlmutter Cancer Center - 34th Street /ID# 257869, New York, New York, United States
  • Duke Cancer Center /ID# 251975, Durham, North Carolina, United States
  • Carolina BioOncology Institute /ID# 225704, Huntersville, North Carolina, United States
  • Perelman Center for Advanced Medicine /ID# 250188, Philadelphia, Pennsylvania, United States
  • UPMC Hillman Cancer Ctr /ID# 225706, Pittsburgh, Pennsylvania, United States
  • Lifespan Cancer Institute at Rhode Island Hospital /ID# 225705, Providence, Rhode Island, United States
  • University of Texas Southwestern Medical Center /ID# 251974, Dallas, Texas, United States
  • University of Texas MD Anderson Cancer Center /ID# 252004, Houston, Texas, United States
  • NEXT Oncology /ID# 225708, San Antonio, Texas, United States
  • Institut Paoli-Calmettes /ID# 260956, Marseille, Bouches-du-Rhone, France
  • IUCT Oncopole /ID# 252673, Toulouse, Occitanie, France
  • Centre Antoine-Lacassagne /ID# 252606, Nice, Provence-Alpes-Côte d'Azur Region, France
  • Hopital Foch /ID# 252607, Suresnes, France
  • Rabin Medical Center /ID# 263631, Petah Tikva, Central District, Israel
  • Hadassah Medical Center /ID# 252366, Jerusalem, Jerusalem, Israel
  • The Chaim Sheba Medical Center /ID# 226756, Ramat Gan, Tel Aviv, Israel
  • National Cancer Center Hospital /ID# 225884, Chuo-ku, Tokyo, Japan
  • Wakayama Medical University Hospital /ID# 252988, Wakayama, Wakayama, Japan
  • Seoul National University Hospital /ID# 254635, Seoul, Seoul Teugbyeolsi, South Korea
  • Samsung Medical Center /ID# 260664, Seoul, Seoul Teugbyeolsi, South Korea
  • Yonsei University Health System Severance Hospital /ID# 260665, Seoul, South Korea
  • Institut Català d'Oncologia (ICO) - L'Hospitalet /ID# 252524, L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Universitario 12 de Octubre /ID# 257374, Madrid, Madrid, Spain
  • Hospital Universitario HM Sanchinarro /ID# 228034, Madrid, Madrid, Spain
View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)